Product Information
BETAMETHASONE DP 0.05% OINT is a generic product labeled by TruPharma LLC, priced at $0.4599 per GM under NDC 52817082415. Its NADAC has been published 221 times since Jul 13, 2022.
FDA first approved this application on Feb 18, 2022. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
.5 mg/g
Manufacturer
TruPharma LLCNDC
52817082415
Classification
Generic
Dosage Form
OINTMENT
Route
TOPICAL
Effective Date
9/23/2026
Active Ingredients
BETAMETHASONE DIPROPIONATEApproval Type
Generic (ANDA)
FDA Application
ANDA215186FDA Approved
2/18/2022
TE Code
AB
On Market Since
2/18/2022
Pharmacological Classes
Price Statistics
The NADAC for BETAMETHASONE DP 0.05% OINT has been published 221 times since Jul 13, 2022, and over the history we have for it it has declined 72.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.4599 per GM |
|---|---|
| All-time high | $1.6648 (Jul 13, 2022) |
| All-time low | $0.4599 (Sep 23, 2026) |
| 52-week high | $0.6753 |
| 52-week low | $0.4599 |
| Median price | $0.6792 |
| Average price | $0.7485 |
| Largest weekly change | +52.5% (Jul 19, 2023) |
| Weeks tracked | 221 |
| Tracking since | Jul 13, 2022 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 24% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
TruPharma LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Betamethasone Dipropionate USP, 0.05% market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Corticosteroid class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of BETAMETHASONE DP 0.05% OINT?
The current National Average Drug Acquisition Cost (NADAC) for BETAMETHASONE DP 0.05% OINT, manufactured by TruPharma LLC, is $0.4599 per GM (NDC 52817082415), effective Sep 30, 2026.
How has the price of BETAMETHASONE DP 0.05% OINT changed over time?
Over the history we have for it, the NADAC for BETAMETHASONE DP 0.05% OINT has declined 72.4%. It has been tracked across 221 weekly CMS publications since Jul 13, 2022.
What are the highest and lowest recorded NADAC prices for BETAMETHASONE DP 0.05% OINT?
Since Jul 13, 2022, the NADAC for BETAMETHASONE DP 0.05% OINT has ranged from a low of $0.4599 (Sep 23, 2026) to a high of $1.6648 (Jul 13, 2022), with a median of $0.6792 per GM.
Are there cheaper alternatives to BETAMETHASONE DP 0.05% OINT?
Yes. 1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, BETAMETHASONE DP 0.05% OINT, is $0.3494 per GM — about 24% below BETAMETHASONE DP 0.05% OINT.
Who manufactures BETAMETHASONE DP 0.05% OINT?
BETAMETHASONE DP 0.05% OINT (NDC 52817082415) is labeled by TruPharma LLC, and CMS classifies it as a generic product.